NASH and Hepatocellular Carcinoma: Immunology and Immunotherapy

Medicine and Dentistry

• Immunology 100%
• Hepatocellular Carcinoma 100%
• Immunotherapy 100%
• Nonalcoholic Fatty Liver 100%
• Diseases 16%
• Immunocompetent Cell 8%
• Clinical Finding 8%
• Carcinogenesis 8%
• Fibrosis 8%
• Liver Cancer 8%
• Liver Cirrhosis 8%
• Cancer Risk 8%
• Disease Management 8%

Keyphrases

• Immunology 100%
• Hepatocellular Carcinoma 100%
• Nonalcoholic Steatohepatitis 100%
• Clinical Translation 9%
• Cirrhosis 9%
• Oncogenesis 9%
• Viral 9%
• Fibrosis 9%
• Patient Survival 9%
• Adaptive Immune Response 9%
• Cancer Risk 9%
• Non-alcoholic Fatty Liver Disease (NAFLD) 9%
• Liver Cancer 9%
• Potential Therapeutics 9%
• Disease Management 9%
• Immunobiology 9%
• Disease Entity 9%
• Innate Immune Cells 9%
• Chemotherapy Resistance 9%
• Conclusive Evidence 9%
• Pro-tumorigenic 9%
• Therapeutic Vulnerabilities 9%
• Immunotherapy Efficacy 9%

Immunology and Microbiology

• Immunology 100%
• Immunotherapy 100%
• Steatohepatitis 100%
• Immunocompetent Cell 9%
• Preclinical Study 9%